Does TEBENTAFUSP-TEBN Cause Metastasis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Metastasis have been filed in association with TEBENTAFUSP-TEBN. This represents 2.0% of all adverse event reports for TEBENTAFUSP-TEBN.
7
Reports of Metastasis with TEBENTAFUSP-TEBN
2.0%
of all TEBENTAFUSP-TEBN reports
1
Deaths
1
Hospitalizations
How Dangerous Is Metastasis From TEBENTAFUSP-TEBN?
Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEBENTAFUSP-TEBN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TEBENTAFUSP-TEBN Cause?
Pyrexia (63)
Cytokine release syndrome (59)
Hypotension (47)
Rash (43)
Disease progression (42)
Chills (38)
Product dose omission issue (37)
Malignant neoplasm progression (32)
Nausea (29)
Vomiting (22)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
Which TEBENTAFUSP-TEBN Alternatives Have Lower Metastasis Risk?
TEBENTAFUSP-TEBN vs TECFIDERA
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M MEDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M OXIDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M PERTECHNETATE